The FDA just fully approved Moderna’s COVID-19 vaccine

A vial of the Moderna COVID-19 vaccine is displayed on a counter at a pharmacy in Portland, Ore., Monday, Dec. 27, 2021. The FDA has full permitted the Moderna COVID-19 vaccine.

Jenny Kane, Related Press

The Meals and Drug Administration Monday permitted a second COVID-19 vaccine — the Moderna COVID-19 vaccine, which will probably be marketed as Spikevax.

What occurred: The FDA mentioned Moderna’s vaccine, known as Spikevac, met the “rigorous requirements for security, effectiveness and manufacturing high quality required for approval.”

• The vaccine has been permitted for emergency use authorization for these 18 years outdated and up.

Quote: “The FDA’s approval of Spikevax is a major step within the struggle in opposition to the COVID-19 pandemic, marking the second vaccine permitted to forestall COVID-19. The general public could be assured that Spikevax meets the FDA’s excessive requirements for security, effectiveness and manufacturing high quality required of any vaccine permitted to be used in the US,” mentioned Dr. Janet Woodcock, the appearing FDA commissioner, in an announcement.

• “Whereas a whole bunch of hundreds of thousands of doses of Moderna COVID-19 vaccine have been administered to people underneath emergency use authorization, we perceive that for some people, FDA approval of this vaccine could instill extra confidence in making the choice to get vaccinated.”

Flashback: In August, the FDA gave full approval of the Pfizer-BioNTech COVID-19 vaccine, saying it could be marketed as Comirnaty (pronounced “koe-mir’-na-tee”).

• On the time, the choice to absolutely approve the Pfizer vaccine appeared like a useful software for companies, which have been trying to require their workers to be vaccine, as I reported for the Deseret Information.